What: A doctor was indicted for writing an abortion pill prescription in a state where such care is banned.
Key line: [Details not provided].
Source: BBC.
A Stanford economist study found that women who sought menopause treatment made 10% less income four years later.
Marty Makary faces controversies as the new FDA commissioner.
RFK Jr. plans to cut 10,000 jobs, causing concerns over public health.
Mouse study reveals female hormones help trigger opioid production in spinal cord immune cells.
Hormone therapy may lower a genetic heart risk factor, new WHI data suggests.
Bladder-leak brand Poise proposes using pads for hormone testing in rural areas.
Study shows women over 70 who screened regularly were diagnosed earlier and had lower mortality.
NPR adds more detail to WHI’s shutdown and the loss of 1990s-era women’s health data.
Report finds mortality jumped in Texas post-ban; researchers call it a canary in the coal mine.
Critical care doctors reveal fatal consequences of abortion bans in new interviews.
The administration froze $35 million in Title X funding, reducing access to birth control and screenings for millions.
Drexel researchers developed a DNA test to help patients with BV avoid the wrong antibiotics and unnecessary side effects.
New Scientist highlights lack of support for bed rest during pregnancy and its risks.
NWLC report warns that birth control access is increasingly under threat post-Roe.
Drew Altman breaks down the real-world consequences of Kennedy’s sweeping HHS overhaul.
One-third of patients spend more than $50,000 on fertility treatments, according to a new survey.
Women who start menopause before age 40 may face faster cognitive decline.
Year-long birth control prescriptions could cut unintended pregnancies and save money, says R Street.
JAMA study shows a 28% increase in maternal deaths from 2018 to 2022.
New report calls women’s health a $360B ‘ghost market’ full of unmet needs across menopause, sexual health, aging, and more.